According
to pre- clinical findings, A novel antiplatelet therapy showed
potential in reducing blood clot risk and preventing cancer metastasis.
The
therapy involves modification of human platelets to create “decoys” that
can bind to certain cells but will not carry out other normal platelet
functions, such as those associated with clotting.
The
reversibility and immediate onset of action are major advantages of
these ‘platelet decoys,’ and it is envisioned to be useful as a
potential antimetastatic therapy and periprocedural antithrombotic
agent.
Explore more such interesting works in hematology at Rome, Italy, this July. To know more, PS: http://bit.ly/2xaW3zT
No comments:
Post a Comment